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1. Introduction 
Biogenetic studies on actinomycin D (fig. l), an 
antibiotic produced by Streptomyces antibioticus, 
have shown that L-valine is a precursor of the D-valine 
and N-methyl-L-valine residues [ I], that L-proline and 
Lthreonine are the precursors of these amino acids in 
the antibiotic [2], and that glycine is a precursor of 
the sarcosine moiety [ 1,3, 51 . The methyl groups of 
sarcosine [4,5], N-methyl-Lvaline [I], and of the 
phenoxazinone nucleus are donated from Lmethio- 
nine [6]. We have studied the biogenesis of this anti- 
biotic at an enzymatic level and here describe the puri- 
fication and some of the properties of an enzyme 
which is probably involved in the activation of L-val- 
ine prior to incorporation into actinomycin D. 
2. Materials and methods 
2.1. General 
Lvaline-’ 4C-U (260 mCi/mM) and sodium ortho- 
phosphate-32P (63 Ci/mg P) were purchased from 
Amersham, Searle, and sodium pyrophosphate-32P 
(835 mCi/mM) from New England Nuclear Co. Radio- 
activity was measured in a Packard scintillation coun- 
ter (model 2002) using Bray’s solution [7] or a tolu- 
ene solution of the same scintillator. 
Protein concentration was estimated by Lowry’s 
method [8] or from the ratio of optical densities at 
280 and 260 nm [9]. 
Isotopic exchange between pyrophosphate or 
phosphate and ATP was measured as described by 
Calendar and Berg [lo] except that the buffer was 
* Present address: lnstitut de Chimie des Substances Natur- 
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Tris-HCl, pH 7.5. The reaction mixture was incubated 
at 30” for 30 min and the reaction stopped by the 
addition of 0.7 ml of 15% perchloric acid containing 
0.4 M cold pyrophosphate or phosphate. After remov- 
al of the precipitate by centrifugation (5,000 g, 10 
min) a 15% suspension of acid-washed Norit A 
(0.1 ml) was added to the supernatant. The mixture 
was stirred vigorously, filtered through glass fibre 
discs (Reeve Angel, no. 934 AH) the filter washed 
with water (4 X 5 ml) and ATP eluted under a slight 
suction with 50% ethanol containing 0.3 M ammonia 
(4 X 1 ml). The radioactivity of the eluate was meas- 
ured. 
One unit of enzyme was defined as the amount in- 
corporating 1 pmole of pyrophosphate into ATP in 
30 mm at 30”. 
L-valine-tRNA formation was estimated by the 
Calendar and Berg method [lo] . The incubation 
mixture contained 100 PM cacodylate buffer, pH 
7.0,5 pmoles MgC12, 0.04 mg bovine serum albumin, 
1 pmole dithiothreitol, 2 pmoles ATP, 200 ymoles 
L-valine-14C-U (lo6 cpm), 1 mg tRNA from S. anti- 
bioticus ATCC 14888 [ 1 l] and enzyme in a total 
vol of 0.5 ml. 
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Fig. 1. Actinomycin D. 
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Table 1 
Ammo acid dependence of ATP-pyrophosphate exchange 
catalysed by crude enzyme extract of cells of S. anlibioticus. 
Amino acid added ATP-pyrophosphate exchange 
(pmoles) 
None 18.0 
L-Valine 61.2 
D-Valine 20.9 
L-Proline 39.0 
L4-Hydroxyproline 22.0 
Sarcosine 22.0 
Glycine 24.1 
L-Threonine 38.7 
N-Methyl-DL-Vsline 22.6 
The exchange reaction was performed as described in Mater- 
ials and methods. To each reaction mixture was added the 
appropriate amino acid (20 PM) and crude enzyme (0.315 mg 
protein). 
The incorporation of I4 C-L-valine into actinomycin 
D and S. antibioticus protein was measured by the 
methods of Weissbach and Katz [ 1, 121 using 6.5 hr 
cells grown in Katz’ media [ 13,141 in a rotary shaker 
at 30”. 
2.2. Enzyme puri’cation 
All operations were performed at 4”. All buffers 
contained 1 mM dithiothreitol and 1 mM MgClz . 
5’. antibioticus cells (65 hr, washed in 5 mM MgCIz) 
in 100 ml 0.1 M Tris-HCl, pH 7 5, containing 20% 
glycerol were sonicated (4 X 15 set) and centrifuged 
(13,000 g, 30 min). Streptomycin sulfate (1.2% final 
concentration) was added to the supernatant and the 
precipitate removed by centrifugation (10,000 g, 20 
min). Solid (NH,) a SO4 (70%) was added to the super- 
natant and the precipitate dissolved in 20 ml 0.05 M 
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Fig. 2. Chromatography of crude enzyme preparation on 
hydroxylapatite. Fractions (5 ml) were collected at 30 min 
intervals. The column was eluted successively with 0.1 M, 
0.15 M, 0.25 M and 0.3 M potassium phosphate buffer, pH 
6.8; the arrows indicate the points at which the buffer was 
changed, (- - - -): Absorbance, A, at 280 nm; (o-o-o): L-valine 
dependent ATP-pyrophosphate (PPi) exchange; (e-04): 
amino acid independent ATP-pyrophosphate xchange. 
phosphate buffer and dialysed against this buffer (2 1) 
for 8 hr. The retentate (referred to as crude enzyme) 
was used in preliminary experiments or subjected to 
the following chromatographic procedures. 
Crude enzyme solution (20 ml) prepared as above 
was applied to a column of hydroxylapatite (Biorad; 
3 X 30 cm) packed in 0.1 M potassium phosphate 
buffer, pH 6.8, and eluted as described in fig. 2. 
Table 2 
Summary of purification of L&line activating enzyme. 
Fraction Volume Protein Total Specific activity Yield 
(ml) (mg) units (units/mg protein) (%) 
Crude enzyme 20 73.0 620 8.5 100 
Hydroxylapatite (Frac. 60-86) 160 35.4 450 12.7 72.5 
Sephadex C-200 (Frac. B-24) 82 22.5 332 14.7 53.5 
DEAE-Sephadex (Frac. 27- 32) 30 3.3 88 26.9 14.2 
L-valine dependent ATP-pyrophosphate exchange was measured as described in the text. 
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Table 3 
Requirements for ATP-pyrophosphate exchange reaction by 
purified enzyme preparation. 
Omission from system ATP-pyrophosphate xchange 
(mrmoles) 
None 40.4 
L-Valine 3.4 
ATP 2.2 
MgClz 2.1 
KF 42.5 
Dithiothreitol 44.3 
EDTA 44.2 
Enzyme 0.3 
The reaction was performed as described in the text; 1 mg of 
purified protein was added to each reaction mixture. 
Fractions 60-86 were pooled, the protein precipitated 
by (NH4)2S04 addition to 70% and redissolved in 
10 ml 0.05 M Tris-HCl buffer, pH 7.5 (buffer 1) and 
dialyzed against this buffer (2 1) for 5 hr. The enzyme 
solution was then applied to a Sephadex G-200 column 
(3 X 40 cm) and eluted with the same buffer (fig. 3). 
Fractions 8-24 were pooled, the protein precipitated 
by (NH4)2S04 (70%) redissolved in 5 ml buffer 1, 
dialyzed against this buffer (2 1,5 hr) and further 
purified by chromatography on a DEAE-Sephadex 
A-25 column (3 X 42 cm) using buffer 1 containing 
a KC1 gradient ranging from O-1 .O M as eluting 
solution (fig. 4). Fractions 27-32 were pooled, gly- 
cerol added to 50% concentration and the solution 
stored at -20”. 
3. Results 
3.1. Properties of crude enzyme 
Of the amino acids tested L-valine stimulated the 
exchange of pyrophosphate into ATP best (table 1). 
Also the preparation contained a large amount of 
amino acid independent ATP-pyrophosphate exchange 
activity. It had no detectable amino acid dependent 
ATP-phosphate exchange activity, but amino acid 
independent activity was detected. 
3.2. Purification of L-valine dependent enzyme 
Chromatography of the crude enzyme on hydroxyl- 
apatite (fig. 2) completely separated the amino acid 
independent activity from the L-valine dependent 
activity. The latter activity was further chromato- 
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Fig. 3. Chromatography on Sephadex C-200. The flow rate 
was 15 ml/hr; fractions were collected every 20 min. (-): 
A 280 nm; (- - -): A 260 nm; (e-o-o): L-valine dependent 
ATP-pyrophosphate (PPi) exchange. 
graphed on Sephadex G-200 (fig. 3) and DEAE-Sepha- 
dex (fig. 4), giving a product which contained < 0.7% 
nucleic acid as judged by the ratio of absorbancies at 
280 and 260 nm. The purification is summarised in 
table 2. 
3.3. Properties of purified enzyme 
ATP-pyrophosphate exchange increased linearly 
with time up to 20 min and was proportional to the 
amount of enzyme added. The exchange reaction re- 
quired L-valine, Mg2+, and ATP (table 3). None of 
the other constituent amino acids of actinomycin 
D nor Lleucine, L-isoleucine, glycine or L-4 hydroxy- 
proline added singly stimulated the exchange. The 
optimal Mg 2+: ATP ratio was 2:5. Complete loss of 
activity was noted when either 1 mM p-chloromer- 
curibenzoate or 1 mM HgClz were added and 50% 
loss when 1 mM thio-bis-2nitrobenzoate was added. 
In a study of the effect of L-valine concentration on 
the ATP-pyrophosphate exchange a K, value of 
0.44 mM was obtained. The enzyme had no catalytic 
effect on the formation of Lvalyl tRNA. This latter 
reaction was catalyzed by the enzyme fraction eluted 
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Fig. 4. Chromatography on DEAE Sephadex A-25. The flow 
rate was 15 mljhr; fractions were collected at 20 min inter- 
vals. (-): A 280 nm; (- - -): A 260 nm; (o-o-o): L-valine de- 
pendent ATP-pyrophosphate (PPi) exchange; (s-v): KC1 grad- 
ient. 
Table 4 
Formation of L-valyl-tRNA and 
ATP-pyrophosphate exchange. 
L-valyl-tRNA 
(cpm) 
Pyrophosphate 
exchanged 
(cpm) 
Experiment I 
Complete system 1,037 6,595 
-tRNA 68 - 
-enzyme 26 - 
Experiment II 
Complete system 45 5,547 
-tRNA 33 _ 
-enzyme 26 - 
The abilities of 2 different enzyme fractions to catalyse L- 
valyl-tRNA formation and ATP-pyrophosphate exchange 
were compared. In experiment IO.5 mg of enzyme protein 
eluted by 0.1 M phosphate from hydroxylapatite column 
was used and in experiment II 0.05 mg of enzyme protein 
from DEAE-Sephadex column. 
Fig. 5. Effect of D-valine on L-valine dependent ATP-pyro- 
phosphate (PPi) exchange. The exchange reaction was 
carried out as described in the text with varying amounts of 
L-valine in the absence (o-o-o), and in the presence (O-O-*) 
of 10 @moles Dvaline. 
Table 5 
Effect of D-valine on actinomycin biosynthesis 
by washed cells. 
D-valine added 
(pmoles) 
Actinomycin 
(cpm) 
Protein 
(cpnl/mg) 
0 1,605 14,300 
10 1,105 18,300 
20 1,030 18,000 
50 726 13,800 
by 0.1 M phosphate buffer from the hydroxyl-apatite 
column (table 4). 
D-valine competitively inhibited Lvaline dependent 
ATP-pyrophosphate exchange (fig. 5) and also inhibi- 
ted incorporation of 14C-L-valine into actinomycin D 
by washed cells (table 5; see also [15]). It had no 
effect on incorporation of Lvaline into cell protein or 
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on Lvalyl-tRNA formation by the enzyme fraction ledged. One of the authors (J.E.W.) is indebted to the 
eluted from the hydroxylapatite column by 0.1 M Wellcome Trust for a travel grant. We are also indeb ted 
phosphate. to Mr. R. Rennin for technical assistance. 
4. Discussion 
The above describes an enzyme which can cause 
the exchange of pyrophosphate into ATP in the pre- 
sence of Lvaline and which does not catalyse the 
transfer of L-valine to tRNA. Its action probably 
requires an active -SH group. Similar enzymes are 
believed to be involved in the biogenesis of other 
peptide antibiotics [161 .The facts that this enzyme 
is present in S. antibioticus at a time when actinomy- 
tin D is being actively synthesized [ 171 and that, 
both the enzyme and actinomycin D production in 
whole cells are inhibited by D-valine, suggest that 
the enzyme is involved in actinomycin biosynthesis. 
However, the ultimate proof of this suggestion will 
come if the enzyme is shown to be involved in the 
cell-free synthesis of actinomycin D from known pre- 
cursors. Extracts prepared under the above and other 
conditions cannot perform such a synthesis efficiently 
]181. 
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